Actavia Life Sciences F/K oranı 2024

Actavia Life Sciences ne yapıyor?

Rasna Therapeutics Inc is a biotech company based in San Francisco, California. It was founded in 2007 with the goal of researching, developing, and marketing innovative therapies for the treatment of cancer and other serious diseases. The company's history goes back to Dr. Raja Srinivasan, an experienced pharmaceutical manager and innovator, who founded the company with a clear vision and high standards for research and development. Rasna Therapeutics has achieved several milestones since then, including clinical trial approvals, the development of promising drugs, and successful financing. The company's business model relies on a comprehensive approach to therapy development, utilizing various technologies and methods to explore and develop a wide range of therapies. Rasna Therapeutics collaborates with leading scientists and experts in the pharmaceutical industry to find innovative solutions and bring products to market that can improve patients' lives. The company operates in various areas, including the development of cancer therapies, treatments for autoimmune diseases and inflammation, and the development of oncolytic viruses. Oncolytic viruses are special viruses that selectively attack and destroy cancer cells while leaving healthy cells intact. Rasna Therapeutics offers various therapeutic ingredients and drug candidates for cancer and autoimmune diseases. These include BCL-2 inhibitors, which inhibit the survival of cancer cells and trigger apoptosis (programmed cell death), as well as IL-15-based therapies, which strengthen the immune system and promote the growth of T cells. The company collaborates closely with scientists and institutions worldwide to share research findings and progress and establish new partnerships. Rasna Therapeutics aims to expand its reach and influence network to achieve long-term success in therapy development and bring successful products to market. Recently, Rasna Therapeutics has also achieved success in the financial world, completing several successful financing rounds and attracting investors who have recognized its potential and innovative approach to therapy development. Overall, Rasna Therapeutics is an innovative biotech company dedicated to developing better therapies for serious diseases. With experienced leadership, partnerships, and groundbreaking approaches, it is able to make valuable progress in therapy development and bring products to market that can improve patients' lives. Actavia Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.